P. Hupperets

Fatigue and Relating Factors in High-Risk Breast Cancer Patients Treated With Adjuvant Standard or High-Dose Chemotherapy: A Longitudinal Study

Peter Nieboer, Ciska Buijs, Sjoerd Rodenhuis et al. · Journal of Clinical Oncology · 2005 · 104 citations · Full text

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer

Sjoerd Rodenhuis, M. Bontenbal, Q.G.C.M. van Hoesel et al. · Annals of Oncology · 2006 · 72 citations

Breast Oncology, Oncology, Her2/neu-negative Breast Cancer +4

Everolimus in combination with weekly paclitaxel and trastuzumab in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab and taxanes: A multicenter phase II clinical trial.

Florence Dalenc, Mario Campone, P. Hupperets et al. · Journal of Clinical Oncology · 2010 · 48 citations

Breast Oncology, Liver Involvement, Immunology +16

Prospective Study of Long-Term Impact of Adjuvant High-Dose and Conventional-Dose Chemotherapy on Health-Related Quality of Life

Ciska Buijs, Sjoerd Rodenhuis, Caroline Seynaeve et al. · Journal of Clinical Oncology · 2007 · 39 citations · Full text

Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice

Peter Frings, Catharina Van Elssen, Lotte Wieten et al. · Breast Cancer Research and Treatment · 2011 · 21 citations

Cell Therapy, Haploidentical Nk Cells, Medicine +9